Literature DB >> 19159953

Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.

DooIl Song1, Yunku Yeo, KeeSoo Ha, GiYoung Jang, JungHwa Lee, KwangChul Lee, ChangSung Son, JooWon Lee.   

Abstract

INTRODUCTION: The clinical manifestations and risk factors for developing coronary artery abnormalities (CAA) in Kawasaki disease (KD) might differ depending on age.
MATERIALS AND METHODS: From January 2001 to July 2007, 161 patients with an age younger than 1 year (younger group) and 60 patients with an age older than 5 years (older group) were diagnosed with KD at the Korea University Medical Center. Their medical records were reviewed retrospectively and the two groups were compared in terms of a number of variables commonly associated with the development of CAA, including clinical manifestations and laboratory findings.
RESULTS: While the overall incidence of KD-associated CAA in our hospital was 6.7%, CAA developed in 20 (12.4%) of the younger group and ten (16.7%) of the older group, respectively. The CAA (+) cases of the younger group had a longer duration of total fever (9.1 +/- 3.3 vs 6.3 +/- 1.9 days, p = 0.002) and showed fewer diagnostic symptoms (3.0 +/- 1.2 vs 4.3 +/- 1.1, p < 0.001) than the CAA (-) cases. The CAA (+) cases of the older group had a longer duration of total fever (14.1 +/- 10.4 vs 6.5 +/- 1.9 days, p = 0.045), especially with respect to post-intravenous gamma globulin (IVGG) fever (7.9 +/- 9.6 vs 1.1 +/- 0.8 days, p = 0.052), and had higher total white blood cell counts, erythrocyte sedimentation rates, C-reactive protein levels, total bilirubin levels, and Harada scores and lower serum albumin and sodium levels than the CAA (-) cases. Multivariable logistic regression analysis revealed that the factors that were associated significantly with the development of CAA were the number of total symptoms (OR = 0.494, 95% confidence interval (CI) = 0.281-0.871, p = 0.015) in the younger group and the duration of post-IVGG fever (OR = 1.958, 95% CI = 1.098-3.492, p = 0.023) and the Harada score (OR = 3.455, 95% CI = 1.012-11.796, p = 0.048) in the older group.
CONCLUSION: Incomplete clinical manifestations in the younger group and IVGG nonresponsiveness in the older group are associated with the development of KD-associated CAA. These age-specific characteristics could aid the customization of the diagnostic and therapeutic strategies of KD, thereby helping to improve the outcome of this disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19159953     DOI: 10.1007/s00431-009-0925-0

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  24 in total

1.  Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset.

Authors:  M Fukunishi; M Kikkawa; K Hamana; T Onodera; K Matsuzaki; Y Matsumoto; J Hara
Journal:  J Pediatr       Date:  2000-08       Impact factor: 4.406

Review 2.  Incomplete (atypical) Kawasaki disease.

Authors:  Anne H Rowley
Journal:  Pediatr Infect Dis J       Date:  2002-06       Impact factor: 2.129

Review 3.  Refractory Kawasaki disease.

Authors:  Alexandra F Freeman; Stanford T Shulman
Journal:  Pediatr Infect Dis J       Date:  2004-05       Impact factor: 2.129

4.  Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease.

Authors:  Hiromi Muta; Masahiro Ishii; Jun Furui; Yosikazu Nakamura; Toyojiro Matsuishi
Journal:  Acta Paediatr       Date:  2006-02       Impact factor: 2.299

5.  Kawasaki disease in infants less than one year of age.

Authors:  E A Rosenfeld; K E Corydon; S T Shulman
Journal:  J Pediatr       Date:  1995-04       Impact factor: 4.406

6.  Age-related changes in polymorphonuclear neutrophil characteristics in infants born to human immunodeficiency virus type 1 seropositive mothers.

Authors:  Stephen Meddows-Taylor; Caroline T Tiemessen
Journal:  Pediatr Allergy Immunol       Date:  2004-04       Impact factor: 6.377

7.  Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association.

Authors: 
Journal:  JAMA       Date:  1992-10-21       Impact factor: 56.272

8.  Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003.

Authors:  Ermias D Belay; Ryan A Maddox; Robert C Holman; Aaron T Curns; Konique Ballah; Lawrence B Schonberger
Journal:  Pediatr Infect Dis J       Date:  2006-03       Impact factor: 2.129

Review 9.  Kawasaki syndrome.

Authors:  Jane C Burns; Mary P Glodé
Journal:  Lancet       Date:  2004 Aug 7-13       Impact factor: 79.321

Review 10.  Advances in Kawasaki disease.

Authors:  Stanford T Shulman; Anne H Rowley
Journal:  Eur J Pediatr       Date:  2004-06       Impact factor: 3.860

View more
  37 in total

1.  Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan.

Authors:  Daisuke Sudo; Yoshiro Monobe; Mayumi Yashiro; Makiko Naka Mieno; Ritei Uehara; Keiji Tsuchiya; Tomoyoshi Sonobe; Yosikazu Nakamura
Journal:  Eur J Pediatr       Date:  2011-12-10       Impact factor: 3.183

2.  High Risk of Coronary Artery Aneurysms in Infants Younger than 6 Months of Age with Kawasaki Disease.

Authors:  Andrea P Salgado; Negar Ashouri; Erika K Berry; Xiaoying Sun; Sonia Jain; Jane C Burns; Adriana H Tremoulet
Journal:  J Pediatr       Date:  2017-04-10       Impact factor: 4.406

3.  Plasma follistatin-like protein 1 is elevated in Kawasaki disease and may predict coronary artery aneurysm formation.

Authors:  Mark Gorelik; David C Wilson; Yona K Cloonan; Stanford T Shulman; Raphael Hirsch
Journal:  J Pediatr       Date:  2012-02-07       Impact factor: 4.406

4.  Evolution of laboratory values in patients with Kawasaki disease.

Authors:  Adriana H Tremoulet; Sonia Jain; Divya Chandrasekar; Xiaoying Sun; Yuichiro Sato; Jane C Burns
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

5.  Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide.

Authors:  Kazunari Kaneko; Ken Yoshimura; Atsushi Ohashi; Takahisa Kimata; Tomohiko Shimo; Shoji Tsuji
Journal:  Pediatr Cardiol       Date:  2011-04-13       Impact factor: 1.655

6.  Complete and incomplete Kawasaki disease: two sides of the same coin.

Authors:  Cedric Manlhiot; Erin Christie; Brian W McCrindle; Hans Rosenberg; Nita Chahal; Rae S M Yeung
Journal:  Eur J Pediatr       Date:  2011-12-03       Impact factor: 3.183

7.  Stratification, Hypothesis Testing, and Clinical Trial Simulation in Pediatric Drug Development.

Authors:  Ann W McMahon; Kevin Watt; Jian Wang; Dionna Green; Ram Tiwari; Gilbert J Burckart
Journal:  Ther Innov Regul Sci       Date:  2016-06-02       Impact factor: 1.778

8.  Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.

Authors:  Lorna Stemberger Maric; Ivica Knezovic; Neven Papic; Branko Mise; Srdan Roglic; Leo Markovinovic; Goran Tesovic
Journal:  Rheumatol Int       Date:  2014-11-28       Impact factor: 2.631

9.  Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis.

Authors:  Kee-Soo Ha; GiYoung Jang; JungHwa Lee; KwangChul Lee; YoungSook Hong; ChangSung Son; JooWon Lee
Journal:  Eur J Pediatr       Date:  2012-11-16       Impact factor: 3.183

10.  Delta-neutrophil index: a potential predictor of coronary artery involvement in Kawasaki disease by retrospective analysis.

Authors:  Sang Hun Lee; Kyung Ok Ko; Jae Woo Lim; Jung Min Yoon; Young Hwa Song; Jong Wook Lee; Eun Jung Cheon
Journal:  Rheumatol Int       Date:  2019-09-23       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.